Literature DB >> 33386322

Principles of Care for Young Adults With Substance Use Disorders.

Michael Silverstein1,2,3, Scott E Hadland4,2,3, Eliza Hallett4,2, Michael Botticelli3.   

Abstract

Despite the disproportionate impact of substance use on young adults, as well as their unique developmental circumstances, there has historically been little attention given to the substance use care needs of this population. As a result, there are currently few evidence-based recommendations to guide clinicians in caring for young adults with substance use disorders. The Grayken Center for Addiction Medicine at Boston Medical Center convened an interdisciplinary meeting of experts to establish principles of care to guide the management of young adults with substance use disorders, to help health care organizations establish effective care systems for these patients, and to help guide policy. In this article, we review the care principles and introduce a series of linked articles that go into further details of principles in the domains of evidence-based substance use treatment, family engagement in care, recovery support services, comorbid psychiatric illness, harm reduction, and criminal justice system reform.
Copyright © 2021 by the American Academy of Pediatrics.

Entities:  

Mesh:

Year:  2021        PMID: 33386322      PMCID: PMC7942818          DOI: 10.1542/peds.2020-023523B

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  7 in total

Review 1.  Shared decision making in psychiatry.

Authors:  J Hamann; S Leucht; W Kissling
Journal:  Acta Psychiatr Scand       Date:  2003-06       Impact factor: 6.392

2.  Women, Co-occurring Disorders, and Violence Study: a case for trauma-informed care.

Authors:  H Westley Clark; A Kathryn Power
Journal:  J Subst Abuse Treat       Date:  2005-03

3.  Release from prison--a high risk of death for former inmates.

Authors:  Ingrid A Binswanger; Marc F Stern; Richard A Deyo; Patrick J Heagerty; Allen Cheadle; Joann G Elmore; Thomas D Koepsell
Journal:  N Engl J Med       Date:  2007-01-11       Impact factor: 91.245

Review 4.  Neurobiology of the adolescent brain and behavior: implications for substance use disorders.

Authors:  B J Casey; Rebecca M Jones
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2010-10-08       Impact factor: 8.829

Review 5.  Prevention, early intervention, harm reduction, and treatment of substance use in young people.

Authors:  Emily Stockings; Wayne D Hall; Michael Lynskey; Katherine I Morley; Nicola Reavley; John Strang; George Patton; Louisa Degenhardt
Journal:  Lancet Psychiatry       Date:  2016-02-18       Impact factor: 27.083

6.  Buprenorphine Treatment By Primary Care Providers, Psychiatrists, Addiction Specialists, And Others.

Authors:  Mark Olfson; Victoria Zhang; Michael Schoenbaum; Marissa King
Journal:  Health Aff (Millwood)       Date:  2020-06       Impact factor: 9.048

Review 7.  Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies.

Authors:  Luis Sordo; Gregorio Barrio; Maria J Bravo; B Iciar Indave; Louisa Degenhardt; Lucas Wiessing; Marica Ferri; Roberto Pastor-Barriuso
Journal:  BMJ       Date:  2017-04-26
  7 in total
  1 in total

1.  Towards an International Consensus on the Prevention, Treatment, and Management of High-Risk Substance Use and Overdose among Youth.

Authors:  Michael Krausz; Jean N Westenberg; Vivian Tsang; Janet Suen; Martha J Ignaszewski; Nickie Mathew; Pouya Azar; Maurice Cabanis; Julie Elsner; Marc Vogel; Renske Spijkerman; Laura Orsolini; Dzung Vo; Eva Moore; Jessica Moe; Johannes Strasser; Patrick Köck; Calin Marian; Kenneth M Dürsteler; Markus Backmund; Jeanette Röhrig; Marianne Post; Hans Haltmayer; Wolfgang Wladika; Thomas Trabi; Christian Muller; Gerhard Rechberger; Maree Teesson; Michael Farrell; Grant Christie; Sally Merry; Mostafa Mamdouh; Rachel Alinsky; Sharon Levy; Marc Fishman; Richard Rosenthal; Kerry Jang; Fiona Choi
Journal:  Medicina (Kaunas)       Date:  2022-04-13       Impact factor: 2.948

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.